Associations of pregnancies and livebirths with postmenopausal osteoporosis odds and modifying effects of physical activity. [PDF]
Wang X +7 more
europepmc +1 more source
Treatment options for postmenopausal osteoporosis
Garry M WalshDivision of Applied Medicine, School of Medicine and Dentistry, Institute of Medical Sciences, University of Aberdeen, United KingdomTo serve our readership better, future editions of Therapeutics and Clinical Risk Management will once again
Walsh GM
core
Comparing Teriparatide and Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of RCTs. [PDF]
Uddin MZ +11 more
europepmc +1 more source
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis. [PDF]
Adami G +10 more
europepmc +1 more source
The role of genomic Copy Number Variation (CNV) in osteoporosis
Copy number variation (CNV) is a relatively novel source of genetic variation, involving the duplication or deletion of segments of genomic DNA (gDNA) sequence, thereby changing the original number of DNA copies.
Connolly, Kate
core
Combined Nanoparticle-Based Delivery of Estrogens and Raloxifen in Postmenopausal Osteoporosis. [PDF]
Włodarczyk A, Dolibog P.
europepmc +1 more source
Association between the nutritional risk index and postmenopausal osteoporosis in patients with type 2 diabetes mellitus. [PDF]
Haibier A, Lin H, Liu W, Li W.
europepmc +1 more source
Synergistic Efficacy of Calcitriol Combined with Denosumab versus Calcitriol Alone in Postmenopausal Osteoporosis: A Retrospective Cohort Study. [PDF]
Li X, Hu M, Shen Y.
europepmc +1 more source
The association between glutathione reductase and postmenopausal osteoporosis: a retrospective study. [PDF]
Wang J +13 more
europepmc +1 more source
Romosozumab Versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: An Overview of Systematic Reviews With Direct and Indirect Meta-Analyses. [PDF]
Bandeira TFGS +4 more
europepmc +1 more source

